Acro Biomedical (ACBM) EPS (Weighted Average and Diluted) (2021 - 2025)

Acro Biomedical (ACBM) recorded quarterly EPS (Weighted Average and Diluted) of $0.0 in Q4 2025, up 136.1% quarter-over-quarter from -$0.0 in Q3 2025, and up 498.44% on a YoY basis from $0.0 in Q4 2024.

Acro Biomedical (ACBM) EPS (Weighted Average and Diluted) (2021 - 2025) Analysis & Trends

Acro Biomedical's EPS (Weighted Average and Diluted) history runs 5 years deep, the most recent figure standing at $0.0 for Q4 2025.

  • In Q4 2025, EPS (Weighted Average and Diluted) rose 498.44% year-over-year to $0.0; the TTM figure through Dec 2025 stood at -$0.0 (down 139.13% YoY), while the FY2025 annual figure was -$0.0, down 139.13% from the prior year.
  • EPS (Weighted Average and Diluted) was $0.0 for Q4 2025 at Acro Biomedical, up from -$0.0 in the prior quarter.
  • In the past five years, EPS (Weighted Average and Diluted) ranged from a high of $0.0 in Q4 2025 to a low of -$0.07 in Q4 2021.
  • Historically, EPS (Weighted Average and Diluted) has averaged -$0.02 across 5 years, with a median of -$0.0 in 2023.
  • Biggest YoY gain for EPS (Weighted Average and Diluted) was 498.44% in 2025; the steepest drop was 1051.72% in 2025.
  • A 5-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.07 in 2021, then grew by 16.08% to -$0.06 in 2022, then soared by 99.49% to -$0.0 in 2023, then jumped by 41.49% to -$0.0 in 2024, then jumped by 498.44% to $0.0 in 2025.
  • The last three EPS (Weighted Average and Diluted) figures came in at $0.0 (Q4 2025), -$0.0 (Q3 2025), and -$0.0 (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Weighted Avg. Diluted) (Qtr)
1 EQV Ventures Acquisition 477.93 Mn 477.93 Mn - 0.07
2 GP-Act III Acquisition 312.80 Mn 312.80 Mn - 0.08
3 Berto Acquisition 311.56 Mn 311.56 Mn - 0.06
4 Churchill Capital Corp IX 310.79 Mn 310.79 Mn - 0.04
5 Centurion Acquisition 310.21 Mn 310.21 Mn - 0.07
6 WEN Acquisition 309.15 Mn 309.15 Mn - 0.08
7 Agriculture & Natural Solutions Acquisition 303.81 Mn 303.81 Mn - 0.07
8 Bold Eagle Acquisition 274.64 Mn 274.64 Mn - 0.07
9 Live Oak Acquisition Corp. V 265.88 Mn 265.88 Mn - -
10 Acro Biomedical - - - 0.00

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 -0.03
Jun 30, 2023 -0.05
Mar 31, 2023 -0.07
Dec 31, 2022 -0.06
Sep 30, 2022 -0.07
Dec 31, 2021 -0.07